Suspensão concentrada (SC) com 1.34% de Bacillus amyloliquefaciens QST 713 (1 x 109 ufc/g) - Søgeresultater

fluticasonpropionat "teva" 50 mikrogram/dosis næsespray, suspension

teva b.v. - fluticasonpropionat - næsespray, suspension - 50 mikrogram/dosis

lutrate depot 3,75 mg pulver og solvens til depotinjektionsvæske, suspension

gp-pharm s.a. - leuprorelinacetat - pulver og solvens til depotinjektionsvæske, suspension - 3,75 mg

symbicort 4,5+160 mikrog/dosis inhalationsspray, suspension

astrazeneca a/s - budesonid, formoterolfumarat dihydrat - inhalationsspray, suspension - 4,5+160 mikrog/dosis

trileptal 60 mg/ml oral suspension

novartis healthcare a/s - oxcarbazepin - oral suspension - 60 mg/ml

azacitidine "stada" 25 mg/ml pulver til injektionsvæske, suspension

stada arzneimittel ag - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml

azacitidine "zentiva" 25 mg/ml pulver til injektionsvæske, suspension

zentiva k.s. - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml

flixotide 125 mikrogram/dosis inhalationsspray, suspension

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationsspray, suspension - 125 mikrogram/dosis

flixotide 250 mikrogram/dosis inhalationsspray, suspension

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationsspray, suspension - 250 mikrogram/dosis

flixotide 50 mikrogram/dosis inhalationsspray, suspension

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationsspray, suspension - 50 mikrogram/dosis

link 150 mg/ml oral suspension

actavis group ptc ehf. - aluminiumhydroxid-magnesiumcarbonat co-prÆcipitat gel - oral suspension - 150 mg/ml